Relationships among uterine growth, ornithine decarboxylase activity and polyamine levels: studies with estradiol and antiestrogens

Ellen A. Rorke, Kari L. Kendra, Benita S Katzenellenbogen

Research output: Contribution to journalArticle

Abstract

We have examined the effects of estradiol (E 2 ) and antiestrogen (AE) on ornithine decarboxylase (ODC) activity and uterine polyamine concentrations as an aid to understanding the dissimilar effects of E 2 and AE on uterine growth. ODC activity rises rapidly from very low levels in immature (day 20-23) rat uteri, showing two markedly (~ 500-fold) increased peaks of activity at 5 h and 16 h after E 2 (2 μg) injection. After AE (50 μg CI628 or U23469) treatment, the temporal increase in ODC activity is slow and only one major peak is found at 24 h. Daily injections of E 2 over a 3-day period evoke continued stimulation of uterine ODC activity; however, the same daily treatment regimen with AE results in stimulation of ODC activity only during the first day. After pretreatment with AE, E 2 can still elicit the early (5 h) peak of ODC activity, but the later (16 h) peak of ODC activity is blocked. Quantitation of uterine polyamines by high performance liquid chromatography reveals a 1.5-2-fold increase in the concentration of spermidine after 1 day of E 2 or AE exposure, with little change in putrescine or spermine levels. After 3 days of E 2 , AE, or E 2 plus AE treatment, spermidine concentrations are elevated 2-2.5-fold and spermine concentrations are elevated 1.5-fold. Putrescine concentrations are unchanged. Hence, regardless of the different degree to which the uterus is stimulated to grow in response to E 2 and/or AE, there are corresponding changes in uterine ODC activity, such that polyamine concentrations are elevated to a similar extent in the E 2 - or AE-treated uterus.

Original languageEnglish (US)
Pages (from-to)31-38
Number of pages8
JournalMolecular and Cellular Endocrinology
Volume38
Issue number1
DOIs
StatePublished - Nov 1984

Fingerprint

Ornithine Decarboxylase
Estrogen Receptor Modulators
Polyamines
Estradiol
Growth
Uterus
Putrescine
Spermidine
Spermine
Nitromifene
Injections
High performance liquid chromatography
Rats
Therapeutics
High Pressure Liquid Chromatography

Keywords

  • estrogen
  • growth
  • spermidine
  • triphenylethylene antiestrogens
  • uterus

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Endocrinology

Cite this

@article{d0c3a8ce06b34321ae29819f3848e015,
title = "Relationships among uterine growth, ornithine decarboxylase activity and polyamine levels: studies with estradiol and antiestrogens",
abstract = "We have examined the effects of estradiol (E 2 ) and antiestrogen (AE) on ornithine decarboxylase (ODC) activity and uterine polyamine concentrations as an aid to understanding the dissimilar effects of E 2 and AE on uterine growth. ODC activity rises rapidly from very low levels in immature (day 20-23) rat uteri, showing two markedly (~ 500-fold) increased peaks of activity at 5 h and 16 h after E 2 (2 μg) injection. After AE (50 μg CI628 or U23469) treatment, the temporal increase in ODC activity is slow and only one major peak is found at 24 h. Daily injections of E 2 over a 3-day period evoke continued stimulation of uterine ODC activity; however, the same daily treatment regimen with AE results in stimulation of ODC activity only during the first day. After pretreatment with AE, E 2 can still elicit the early (5 h) peak of ODC activity, but the later (16 h) peak of ODC activity is blocked. Quantitation of uterine polyamines by high performance liquid chromatography reveals a 1.5-2-fold increase in the concentration of spermidine after 1 day of E 2 or AE exposure, with little change in putrescine or spermine levels. After 3 days of E 2 , AE, or E 2 plus AE treatment, spermidine concentrations are elevated 2-2.5-fold and spermine concentrations are elevated 1.5-fold. Putrescine concentrations are unchanged. Hence, regardless of the different degree to which the uterus is stimulated to grow in response to E 2 and/or AE, there are corresponding changes in uterine ODC activity, such that polyamine concentrations are elevated to a similar extent in the E 2 - or AE-treated uterus.",
keywords = "estrogen, growth, spermidine, triphenylethylene antiestrogens, uterus",
author = "Rorke, {Ellen A.} and Kendra, {Kari L.} and Katzenellenbogen, {Benita S}",
year = "1984",
month = "11",
doi = "10.1016/0303-7207(84)90142-4",
language = "English (US)",
volume = "38",
pages = "31--38",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Relationships among uterine growth, ornithine decarboxylase activity and polyamine levels

T2 - studies with estradiol and antiestrogens

AU - Rorke, Ellen A.

AU - Kendra, Kari L.

AU - Katzenellenbogen, Benita S

PY - 1984/11

Y1 - 1984/11

N2 - We have examined the effects of estradiol (E 2 ) and antiestrogen (AE) on ornithine decarboxylase (ODC) activity and uterine polyamine concentrations as an aid to understanding the dissimilar effects of E 2 and AE on uterine growth. ODC activity rises rapidly from very low levels in immature (day 20-23) rat uteri, showing two markedly (~ 500-fold) increased peaks of activity at 5 h and 16 h after E 2 (2 μg) injection. After AE (50 μg CI628 or U23469) treatment, the temporal increase in ODC activity is slow and only one major peak is found at 24 h. Daily injections of E 2 over a 3-day period evoke continued stimulation of uterine ODC activity; however, the same daily treatment regimen with AE results in stimulation of ODC activity only during the first day. After pretreatment with AE, E 2 can still elicit the early (5 h) peak of ODC activity, but the later (16 h) peak of ODC activity is blocked. Quantitation of uterine polyamines by high performance liquid chromatography reveals a 1.5-2-fold increase in the concentration of spermidine after 1 day of E 2 or AE exposure, with little change in putrescine or spermine levels. After 3 days of E 2 , AE, or E 2 plus AE treatment, spermidine concentrations are elevated 2-2.5-fold and spermine concentrations are elevated 1.5-fold. Putrescine concentrations are unchanged. Hence, regardless of the different degree to which the uterus is stimulated to grow in response to E 2 and/or AE, there are corresponding changes in uterine ODC activity, such that polyamine concentrations are elevated to a similar extent in the E 2 - or AE-treated uterus.

AB - We have examined the effects of estradiol (E 2 ) and antiestrogen (AE) on ornithine decarboxylase (ODC) activity and uterine polyamine concentrations as an aid to understanding the dissimilar effects of E 2 and AE on uterine growth. ODC activity rises rapidly from very low levels in immature (day 20-23) rat uteri, showing two markedly (~ 500-fold) increased peaks of activity at 5 h and 16 h after E 2 (2 μg) injection. After AE (50 μg CI628 or U23469) treatment, the temporal increase in ODC activity is slow and only one major peak is found at 24 h. Daily injections of E 2 over a 3-day period evoke continued stimulation of uterine ODC activity; however, the same daily treatment regimen with AE results in stimulation of ODC activity only during the first day. After pretreatment with AE, E 2 can still elicit the early (5 h) peak of ODC activity, but the later (16 h) peak of ODC activity is blocked. Quantitation of uterine polyamines by high performance liquid chromatography reveals a 1.5-2-fold increase in the concentration of spermidine after 1 day of E 2 or AE exposure, with little change in putrescine or spermine levels. After 3 days of E 2 , AE, or E 2 plus AE treatment, spermidine concentrations are elevated 2-2.5-fold and spermine concentrations are elevated 1.5-fold. Putrescine concentrations are unchanged. Hence, regardless of the different degree to which the uterus is stimulated to grow in response to E 2 and/or AE, there are corresponding changes in uterine ODC activity, such that polyamine concentrations are elevated to a similar extent in the E 2 - or AE-treated uterus.

KW - estrogen

KW - growth

KW - spermidine

KW - triphenylethylene antiestrogens

KW - uterus

UR - http://www.scopus.com/inward/record.url?scp=0021714894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021714894&partnerID=8YFLogxK

U2 - 10.1016/0303-7207(84)90142-4

DO - 10.1016/0303-7207(84)90142-4

M3 - Article

C2 - 6394408

AN - SCOPUS:0021714894

VL - 38

SP - 31

EP - 38

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1

ER -